These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 19666239)

  • 1. Experimental immunotherapeutic approaches for atherosclerosis.
    Amir S; Binder CJ
    Clin Immunol; 2010 Jan; 134(1):66-79. PubMed ID: 19666239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunity and Inflammation in Atherosclerosis.
    Wolf D; Ley K
    Circ Res; 2019 Jan; 124(2):315-327. PubMed ID: 30653442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherosclerosis and immunity: A perspective.
    Abdolmaleki F; Gheibi Hayat SM; Bianconi V; Johnston TP; Sahebkar A
    Trends Cardiovasc Med; 2019 Aug; 29(6):363-371. PubMed ID: 30292470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2016 Jeffrey M. Hoeg Award Lecture.
    Rouwet E; Lutgens E
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1678-1688. PubMed ID: 29930003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring immune checkpoints as potential therapeutic targets in atherosclerosis.
    Kusters PJH; Lutgens E; Seijkens TTP
    Cardiovasc Res; 2018 Mar; 114(3):368-377. PubMed ID: 29309533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive Response of T and B Cells in Atherosclerosis.
    Ketelhuth DF; Hansson GK
    Circ Res; 2016 Feb; 118(4):668-78. PubMed ID: 26892965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of innate and adaptive immune responses on atherosclerosis.
    Witztum JL; Lichtman AH
    Annu Rev Pathol; 2014; 9():73-102. PubMed ID: 23937439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammasome, T Lymphocytes and Innate-Adaptive Immunity Crosstalk: Role in Cardiovascular Disease and Therapeutic Perspectives.
    Pedicino D; Giglio AF; Ruggio A; Massaro G; D'Aiello A; Trotta F; Lucci C; Graziani F; Biasucci LM; Crea F; Liuzzo G
    Thromb Haemost; 2018 Aug; 118(8):1352-1369. PubMed ID: 29991092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the immune response in atherosclerosis: It's time for clinical trials!
    Joffre J; Ait-Oufella H
    Arch Cardiovasc Dis; 2017 Dec; 110(12):643-645. PubMed ID: 29051009
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune-Inflammation in Atherosclerosis: A New Twist in an Old Tale.
    Talepoor AG; Fouladseresht H; Khosropanah S; Doroudchi M
    Endocr Metab Immune Disord Drug Targets; 2020; 20(4):525-545. PubMed ID: 31622224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoimmunotherapy to treat ischaemic heart disease.
    Duivenvoorden R; Senders ML; van Leent MMT; Pérez-Medina C; Nahrendorf M; Fayad ZA; Mulder WJM
    Nat Rev Cardiol; 2019 Jan; 16(1):21-32. PubMed ID: 30209355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptive T cell immune responses and atherogenesis.
    Taleb S; Tedgui A; Mallat Z
    Curr Opin Pharmacol; 2010 Apr; 10(2):197-202. PubMed ID: 20207195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immune cells in atherosclerosis--good or bad?].
    Klingenberg R; Matter CM; Lüscher TF
    Praxis (Bern 1994); 2016 Apr; 105(8):437-44. PubMed ID: 27078727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptive immunity and atherosclerosis.
    Andersson J; Libby P; Hansson GK
    Clin Immunol; 2010 Jan; 134(1):33-46. PubMed ID: 19635683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trained Immunity in Atherosclerotic Cardiovascular Disease.
    Flores-Gomez D; Bekkering S; Netea MG; Riksen NP
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):62-69. PubMed ID: 33147995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination Strategies and Immune Modulation of Atherosclerosis.
    Nilsson J; Hansson GK
    Circ Res; 2020 Apr; 126(9):1281-1296. PubMed ID: 32324498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An inflammatory link in atherosclerosis and obesity. Co-stimulatory molecules.
    Zirlik A; Lutgens E
    Hamostaseologie; 2015; 35(3):272-8. PubMed ID: 26225729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting inflammation in cardiovascular diseases. still a neglected field?
    Gómez-Guerrero C; Mallavia B; Egido J
    Cardiovasc Ther; 2012 Aug; 30(4):e189-97. PubMed ID: 21884009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines and Immune Responses in Murine Atherosclerosis.
    Kusters PJ; Lutgens E
    Methods Mol Biol; 2015; 1339():17-40. PubMed ID: 26445779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Danger signaling in atherosclerosis.
    Zimmer S; Grebe A; Latz E
    Circ Res; 2015 Jan; 116(2):323-40. PubMed ID: 25593277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.